Commonwealth Equity Services
ACHN

Commonwealth Equity Services’s Achillion Pharmaceuticals ACHN Stock Holding History

Commonwealth Equity Services’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-16,775
Closed -$205K – 2238
2014
Q4 		$205K Buy
+16,775
New +$205K ﹤0.01% 1837

Other funds holding ACHN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commonwealth Equity Services's ACHN Position: Q1 2015 in Review

Commonwealth Equity Services sold out of Achillion Pharmaceuticals (ACHN) in Q1 2015, closing a stake of 16,775 shares — an estimated $205K sold.

Commonwealth Equity Services first reported a position in ACHN in Q4 2014 and held it in 1 quarter. The position peaked at $205K in Q4 2014. 173 funds tracked by Wall St. Rank hold ACHN as of Q1 2015.

  • Commonwealth Equity Services reported no remaining Achillion Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Commonwealth Equity Services sold 16,775 Achillion Pharmaceuticals shares in Q1 2015, an estimated $205K.
  • Commonwealth Equity Services first reported a position in Achillion Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • Commonwealth Equity Services's Achillion Pharmaceuticals position peaked at $205K in Q4 2014.
  • 173 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2015.

Based on Commonwealth Equity Services's 13F filing for Q1 2015, filed 28 Apr 2015.